Pediatric Drug Development

Specialized expertise in developing safe and effective medicines for children

Children's Health Innovation

Oracle BioTech specializes in pediatric drug development, addressing the unique physiological and developmental considerations required for safe and effective treatments in children from neonates to adolescents.

Pediatric Care

Pediatric Oncology

Developing age-appropriate cancer treatments with improved safety profiles and formulations specifically designed for children.

  • Childhood leukemia treatments
  • Pediatric solid tumor therapies
  • Age-appropriate formulations
  • Long-term safety monitoring
Learn More
Pediatric Medical Team

Rare Pediatric Diseases

Focused development programs for rare genetic and metabolic disorders affecting children with unmet medical needs.

  • Genetic disorder treatments
  • Metabolic disease therapies
  • Neurodevelopmental disorders
  • Orphan drug development
Learn More

Pediatric Development Pipeline

Preclinical

4 Programs

Juvenile animal studies and safety assessment.

Phase I

3 Programs

Pediatric safety and dosing studies.

Phase II

2 Programs

Efficacy studies in pediatric populations.

Phase III

1 Program

Confirmatory trial for pediatric rare disease treatment.

Approved

2 Products

FDA-approved pediatric treatments.